GlassScriptPhysician profile
Rey Ximenes
NPI 1801816228
$1,355.85
in general payments reported to CMS, 2019-2025
17 companies · $294 in 2025
The $294 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $237 · 2021: $108 · 2022: $160 · 2023: $155 · 2024: $220 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $669.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $277.89 | 2019-2023 | Proclaim |
| Abbvie INC. | $152.02 | 2022-2024 | Qulipta, Ubrelvy |
| Inspire Medical Systems, INC. | $145.67 | 2025 | Inspire |
| Biodelivery Sciences International, INC. | $124.41 | 2019 | |
| Teleflex LLC | $110.93 | 2025 | Barrigel |
| Collegium Pharmaceutical, INC. | $104.83 | 2022-2023 | Belbuca |
| Johnson & Johnson Surgical Vision, INC. | $77.65 | 2024 | Tecnis Simplicity |
| Stimwave Technologies Incorporated | $69.91 | 2020 | |
| Pfizer INC. | $66.24 | 2019-2021 | |
| Spr Therapeutics, INC | $48.00 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $37.30 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $37.09 | 2022 | |
| Braeburn INC. | $29.11 | 2024 | Brixadi |
| Averitas Pharma INC. | $27.12 | 2024 | Qutenza |
| Grt US Holding, INC. | $20.58 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $15.55 | 2023 | Tirosint, Licart |
| Spinesmith Holdings, LLC | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rey Ximenes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.